Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data

Eurosurveillance

Volumn 19, Issue 44, 2014, Pages

  Gefenaite, G ^a,b   Bijlsma, M J ^a   Bos, H J ^a   Hak, E ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; COTRIMOXAZOLE; PNEUMOCOCCUS VACCINE; RESPIRATORY TRACT AGENT;

ARTICLE; CHILD; DRUG USE; HUMAN; NETHERLANDS; PRESCHOOL CHILD; PRESCRIPTION; STUDY DESIGN; VACCINATION;

EID: 84922031861     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.44.20948     Document Type: Article

References (22)

1. Otters HB, van der Wouden JC, Schellevis FG, van Suijlekom-Smit LW, Koes BW. Trends in prescribing antibiotics for children in Dutch general practice. J Antimicrob Chemother. 2004; 53(2): 361-6. http: //dx.doi.org/10.1093/jac/dkh062
2. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of communityacquired pneumonia in hospitalized children. Pediatrics. 2004; 113(4): 701-7. http: //dx.doi.org/10.1542/peds.113.4.701
3. van Lier EA, Oomen PJ, Giesbers H, Drijfhout IH, de Hoogh PA, de Melker HE. Vaccinatiegraad Rijksvaccinatieprogramma Nederland.Verslagjaar 2011. [Immunization coverage National Immunization Programme in the Netherlands: Year of report 2011]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2011. Report 210021014/2011. Dutch. Available from: http: //www.rivm.nl/bibliotheek/ rapporten/210021014.pdf
4. de Bont EG, van Loo IH, Dukers-Muijrers NH, Hoebe CJ, Bruggeman CA, Dinant GJ, et al. Oral and topical antibiotic prescriptions for children in general practice. Arch Dis Child. 2013; 98(3): 228-31. http: //dx.doi.org/10.1136/ archdischild-2012-303134
5. Uijen JH, Bindels PJ, Schellevis FG, van der Wouden JC. ENT problems in Dutch children: trends in incidence rates, antibiotic prescribing and referrals 2002-2008. Scand J Prim Health Care. 2011; 29(2): 75-9. http: //dx.doi.org/10.3109/02813 432.2011.569140
6. Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis. 2010; 16(5): 816-23. http: //dx.doi.org/10.3201/eid1605.091223
7. Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, et al. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.Vaccine. 2012; 30(52): 7644-7644-51 http: //dx.doi.org/10.1016/j.vaccine.2012.04.021
8. van't Klooster T, de Melker H. The National Immunisation Programme in the Netherlands: Developments in 2011. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2012. Report 210021015/2011 Available from: http: //www.rivm.nl/dsresource?objectid=rivmp: 121041&t ype=org&disposition=inline&ns_nc=1
9. Dutch College of General Practitioners (NHG). NHG-Standaard, Otitis media acuta bij kinderenM09 (Actualisering 2013: herzient.o.v. de versie van 2006). [The Dutch College of General Practitioners Guidelines, Otitis media acuta in children M09 (Updated in 2013: based on the version of 2006)]. Utrecht: NHG; 2006 (in revision). [Accessed 19 Mar 2013]. Dutch. Available from: http: //nhg.artsennet.nl/kenniscentrum/k_ richtlijnen/k_nhgstandaarden/Samenvattingskaartje-NHGStandaard/M09_svk.htm
10. Dutch College of General Practitioners (NHG).NHGStandaarden, Acuut hoesten M78 (Actualisering 2013: herzien t.o.v. de versie van 2011). [The Dutch College of General Practitioners Guidelines, Acute cough M78 (Updated in 2013: based on the version of 2011)]. Utrecht: NHG; 2013. [Accessed 19 Mar 2013]. Dutch. Available from: http: //nhg. artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/ Samenvattingskaartje-NHGStandaard/M78_svk.htm
11. Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB. nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res. 2013; 13(3): 285-92. http: //dx.doi.org/10.1586/erp.13.20
12. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2005. Oslo: WHO Collaborating Centre for Drug Statistics Methodology. [Accessed 19 Mar 2013].
13. Cowpertwait PS, Metcalfe AV. Introductory time series with R. Berlin: Springer; 2009.
14. Box GE, Jenkins GM, Reinsel GC. Time series analysis, forecasting and control. 3rd ed. Englewood Cliff, NJ: Prentice Hall; 1994.
15. Box GE, Tiao GC. Intervention analysis with applications to economic and environmental problems. J Am StatAssoc. 1975; 70(349): 70-9. http: //dx.doi.org/10.1080/01621459.1975. 10480264
16. HuitemaBE, Mckean JW. Design specification issues in time-series intervention models. Educ Psychol Meas. 2000; 60(1): 38-58. http: //dx.doi.org/10.1177/00131640021970358
17. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27(4): 299-309 http: //dx.doi.org/10.1046/j.1365-2710.2002.00430.x
18. Time-series analysis. In: Tabachnick B, Fidell L. Using multivariate statistics. 5th ed. Chapter 18. Needham Heights, MA: Allyn & Bacon; 2006.
19. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996; 5(3): 299-314.
20. Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman KP. Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med. 2014; 2(5): 387-94 http: //dx.doi.org/10.1016/ S2213-2600(14)70032-3
21. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365(9459): 579-87. http: //dx.doi.org/10.1016/ S0140-6736(05)17907-0
22. Weil Olivier C. Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children. Med Mal Infect. 2013; 43(8): 309-21. http: //dx.doi.org/10.1016/j. medmal.2013.04.006